Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-035475

Chairman and CEO bought 6,200 shares at an average $1.70 ($10,548)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-06-08 Purchase +2,700 $1.69 $4,563 10,659,893 D
Niihara Yutaka Chairman and CEO 2020-06-09 Purchase +3,500 $1.71 $5,985 10,663,393 D
Open-market purchases · 6,200 sh · avg $1.70 · $10,548
Loading xslF345X03/doc4.xml…